Your browser doesn't support javascript.
loading
COVID-19 pandemic-associated chilblains: more links for SARS-CoV-2 and less evidence for high interferon type I systemic response.
Bessis, Didier; Trouillet-Assant, Sophie; Secco, Léo-Paul; Bardin, Nathalie; Blanc, Brigitte; Blatière, Véronique; Chable-Bessia, Christine; Delfour, Christophe; Girard, Céline; Richard, Jean-Christophe; Gros, Nathalie; Le Moing, Vincent; Molinari, Nicolas; Pallure, Valérie; Pisoni, Amandine; Raison-Peyron, Nadia; Reynaud, Elisa; Schwob, Émilie; Pescarmona, Rémi; Samaran, Quentin; Willems, Marjolaine; Vincent, Thierry; Sofonea, Mircea T; Belot, Alexandre; Tuaillon, Édouard.
Afiliação
  • Bessis D; Department of Dermatology, Saint-Eloi Hospital, Competence Centre for Rare Skin Diseases and University of Montpellier, Montpellier, France.
  • Trouillet-Assant S; INSERM U1058, Montpellier, France.
  • Bardin N; Department of Dermatology, Saint-Eloi Hospital, Competence Centre for Rare Skin Diseases and University of Montpellier, Montpellier, France.
  • Chable-Bessia C; Department of Dermatology, Saint-Eloi Hospital, Competence Centre for Rare Skin Diseases and University of Montpellier, Montpellier, France.
  • Richard JC; Department of Dermatology, Saint-Eloi Hospital, Competence Centre for Rare Skin Diseases and University of Montpellier, Montpellier, France.
  • Gros N; INSERM U1058, Montpellier, France.
  • Schwob É; Department of Dermatology, Saint-Eloi Hospital, Competence Centre for Rare Skin Diseases and University of Montpellier, Montpellier, France.
  • Samaran Q; Department of Dermatology, Saint-Eloi Hospital, Competence Centre for Rare Skin Diseases and University of Montpellier, Montpellier, France.
  • Vincent T; Department of Dermatology, Saint-Eloi Hospital, Competence Centre for Rare Skin Diseases and University of Montpellier, Montpellier, France.
Br J Dermatol ; 187(6): 1032-1035, 2022 12.
Article em En | MEDLINE | ID: mdl-35971922

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Pérnio / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interferon Tipo I / Pérnio / COVID-19 Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Br J Dermatol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França